Ligand-independent activation of the oestrogen receptor by mutation of a conserved tyrosine

EMBO Journal

Volumn 16, Issue 6, 1997, Pages 1427-1435

  White, Roger ^a   Sjöberg, Maria ^a   Kalkhoven, Eric ^a   Parker, Malcolm G ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Co activators; Conserved tyrosine; Ligand independent; Oestrogen receptor

Indexed keywords

BINDING PROTEIN; CELL NUCLEUS RECEPTOR; ESTRADIOL; ESTROGEN RECEPTOR; TRANSCRIPTION FACTOR; TYROSINE;

ALPHA HELIX; AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; GENE MUTATION; GENETIC CONSERVATION; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; HYDROPHOBICITY; LIGAND BINDING; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSACTIVATION;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BINDING SITES; CONSERVED SEQUENCE; DNA; HELA CELLS; HISTONE ACETYLTRANSFERASES; HUMANS; LIGANDS; MICE; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; MUTATION; NUCLEAR PORE COMPLEX PROTEINS; NUCLEAR PROTEINS; PLASMIDS; PROTEIN BINDING; RECEPTORS, ESTROGEN; RNA-BINDING PROTEINS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSFECTION; TYROSINE;

EID: 0342547258     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/16.6.1427     Document Type: Article

References (66)

1. Ali, S., Metzger, D., Bornert, J.-M. and Chambon, P. (1993) Modulation of transcriptional activation by ligand-dependent phosphorylation of the human oestrogen receptor A/B region. EMBO J., 12, 1153-1160.
2. Arnold, S.F., Obourn, J.D., Jaffe, H. and Notides, A.C. (1995a) Phosphorylation of the human estrogen receptor on tyrosine-537 in vivo and by Src family tyrosine kinases in vitro. Mol. Endocrinol., 9, 24-33.
3. Arnold, S.F., Obourn, J.D., Jaffe, H. and Notides, A.C. (1995b) Serine 167 is the major estradiol-induced phosphorylation site on the human estrogen receptor. Mol. Endocrinol., 8, 1208-1214.
4. Arnold, S.F., Obourn, J.D., Yudt, M.R., Carter, T.H. and Notides, A.C. (1995c) In vivo and in vitro phosphorylation of the human estrogen receptor. J. Steroid Biochem. Mol. Biol., 52, 159-171.
5. Arnold, S.F., Vorojeikkina, D.P. and Notides, A.C. (1995d) Phosphorylation of tyrosine 537 on the human estrogen receptor is required for binding to an estrogen response element. J. Biol. Chem., 270, 30205-30212.
6. Aronica, S.M. and Katzenellenbogen, B. (1993) Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-1. Mol. Endocrinol., 7, 743-752.
7. Aronica, S.M., Kraus, W.L. and Katzenellenbogen, B.S. (1994) Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc. Natl Acad. Sci. USA, 91, 8517-8521.
8. Auricchio, F., Migliaccio, A., Di Domenico, M. and Nola, E. (1987) Oestradiol stimulates tyrosine phosphorylation and hormone binding activity of its own receptor in a cell-free system. EMBO J., 6, 2923-2929.
9. Barettino, D., Ruiz, M.D.M.V. and Stunnenberg, H.G. (1994) Characterization of the ligand-dependent transactivation domain of thyroid-hormone receptor. EMBO J., 13, 3039-3049.
10. Beato, M., Herrlich, P. and Schutz, G. (1995) Steroid-hormone receptors -many actors in search of a plot. Cell, 83, 851-857.
11. Bohen, S.P., Kralli, A. and Yamamoto, K.R. (1995) Hold 'em and fold 'em: chaperones and signal transduction. Science, 268, 1303-1304.
12. Bourguet, W., Ruff, M., Chambon, P., Gronemeyer, H. and Moras, D. (1995) Crystal-structure of the ligand-binding domain of the human nuclear receptor RXR-alpha. Nature, 375, 377-382.
13. Bunone, G., Briand, P.-A., Miksicek, R.J. and Picard, D. (1996) Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J., 15, 2174-2183.
14. Caplan, A.J., Langley, E., Wilson, E.M. and Vidal, J. (1995) Hormone dependent transactivation by the human androgen receptor is regulated by a dnaJ protein. J. Biol. Chem., 270, 5251-5257.
15. Castoria, G., Migliaccio, A., Green, S., Di Domenico, M., Chambon, P. and Auricchio, F. (1993) Properties of a purified estradiol-dependent calf uterus tyrosine kinase. Biochemistry, 32, 1740-1750.
16. Castoria, G., Migliaccio, A., Bilancio, A., Pagano, M., Abbondanza, C. and Auricchio, F. (1996) A 67 kDa non-hormone binding estradiol-receptor is present in human mammary cancers. Int. J. Cancer, 65, 574-583.
17. Cavaillès, V., Dauvois, S., Danielian, P.S. and Parker, M.G. (1994) Interaction of proteins with transcriptionally active estrogen receptors. Proc. Natl Acad. Sci. USA, 91, 10009-10013.
18. Cavaillès, V., Dauvois, S., L'Horset, F., Lopez, G., Hoare, S., Kushner, P.J. and Parker, M.G. (1995) Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J., 14, 3741-3751.
19. Chakravarti, D., LaMorte, V.J., Nelson, M.C., Nakajima, T., Schulman, I.G., Juguilon, H., Montminy, M. and Evans, R.M. (1996) Role of CBP/P300 in nuclear receptor signalling. Nature, 383, 99-103.
20. Chen, C. and Okayama, H. (1987) High efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol., 7, 2745-2752.
21. 2-integrin subunit is inhibited in c-erbB2-transfected human mammary epithelial cells. Oncogene, 8, 1797-1806.
22. Danielian, P.S., White, R., Lees, J.A. and Parker, M.G. (1992) Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J., 11, 1025-1033.
23. Durand, B., Saunder, M., Gaudon, C., Roy, B., Losson, R. and Chambon, P. (1994) Activation function 2 (AF-2) of retinoic acid receptor and 9-cis retinoic acid receptor: presence of a conserved autonomous constitutive activating domain and influence of the nature of the response element on AF-2 activity. EMBO J., 13, 5370-5382.
24. Fawell, S.E., Lees, J.A., White, R. and Parker, M.G. (1990a) Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor. Cell, 60, 953-962.
25. Fawell, S.E., White, R., Hoare, S., Sydenham, M., Page, M. and Parker, M.G. (1990b) Inhibition of estrogen receptor-DNA binding by the 'pure' antiestrogen ICI 164,384 appears to be mediated by impaired receptor dimerization. Proc. Natl Acad. Sci. USA, 87, 6883-6887.
26. Green, S., Isseman, I. and Sheer, E. (1988) A versatile in vivo and in vitro eukaryotic expression vector for protein engineering. Nucleic Acids Res., 16, 369.
27. Halachmi, S., Marden, E., Martin, G., MacKay, H., Abbondanza, C. and Brown, M. (1994) Estrogen receptor-associated proteins - possible mediators of hormone-induced transcription. Science, 264, 1455-1458.
28. Henttu, P.M.A., Kalkhoven, E. and Parker, M.G. (1997) AF-2 activity and recruitment of the coactivator SRC-1 to the estrogen receptor depend on lysine residue conserved in nuclear receptors. Mol. Cell. Biol., in press.
29. Ignar-Trowbridge, D.M., Nelson, K.G., Bidwell, M.C., Curtis, S.W., Washburn, T.F., McLachlan, J.A. and Korach, K.S. (1992) Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor. Proc. Natl Acad. Sci. USA, 89, 4658-4662.
30. Ignar-Trowbridge, D.M., Pimentel, M., Parker, M.G., McLachlan, J.A. and Korach, K.S. (1996) Peptide growth factor cross-talk with the estrogen receptor requires the A/B domain and occurs independently of protein kinase C or estradiol. Endocrinology, 137, 1735-1744.
31. Kamei, Y. et al. (1996) A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell, 85, 403-414.
32. Kato, S. et al. (1995) Activation of the estrogen-receptor through phosphorylation by mitogen-activated protein-kinase. Science, 270, 1491-1494.
33. Kimura, Y., Yahara, I. and Lindquist, S. (1995) Role of the protein chaperone YDJ1 in establishing Hsp90-mediated signal transduction pathways. Science, 268, 1362-1365.
34. Ktistaki, E., Ktistakis, N.T., Papadogeorgaki, E. and Talianidis, I. (1995) Recruitment of hepatocyte nuclear factor 4 into specific intranuclear compartments depends on tyrosine phosphorylation that affects its DNA-binding and transactivation potential. Proc. Natl Acad. Sci. USA, 92, 9876-9880.
35. Kuiper, G.G.J.M., Enmark, E., Pelto-Huikko, M., Nilsson, S. and Gustafsson, J.-A. (1996) Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc. Natl Acad. Sci. USA, 93, 5925-5930.
36. Kurokawa, R., Soderstrom, M., Horlein, A., Halachmi, S., Brown, M., Rosenfeld, M.G. and Glass, C.K. (1995) Polarity-specific activities of retinoic acid receptors determined by a co-repressor Nature, 377, 451-454.
37. Lahooti, H., White, R., Danielian, P.S. and Parker, M.G. (1994) Characterization of ligand-dependent phosphorylation of the estrogen receptor. Mol. Endocrinol., 8, 182-188.
38. Lahooti, H., White, R., Hoare, S.A., Rahman, D., Pappin, D.J.C. and Parker, M.G. (1995) Identification of phosphorylation sites in the mouse estrogen-receptor. J. Steroid Biochem., 55, 305-313.
39. Le Douarin, B. et al. (1995) The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J., 14, 2020-2033.
40. Le Goff, P., Montano, M.M., Schodin, D.J. and Katzenellenbogen, B.S. (1994) Phosphorylation of the human estrogen receptor. J. Biol. Chem., 269, 4458-4466.
41. Lee, J.W., Ryan, F., Swaffield, J.C., Johnston, S.A. and Moore, D.D. (1995) Interaction of thyroid-hormone receptor with a conserved transcriptional mediator. Nature, 374, 91-94.
42. Lees, J.A., Fawell, S.E. and Parker, M.G. (1989) Identification of two transactivation domains in the mouse oestrogen receptor. Nucleic Acids Res., 17, 5477-5488.
43. Lillie, J.W. and Green, M.R. (1989) Transcription activation by the adenovirus E1a protein. Nature, 338, 39-44.
44. Lin, K.-H., Ashizawa, K. and Cheng, S.-Y. (1992) Phosphorylation stimulates the transcriptional activity of the human β1 thyroid hormone nuclear receptor. Proc. Natl Acad. Sci. USA, 89, 7737-7741.
45. Mangelsdorf, D.J. et al. (1995) The nuclear receptor superfamily: the second decade. Cell, 83, 835-839.
46. ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J., 15, 1292-1300.
47. Mosselman, S., Polman, J. and Dijkema, R. (1996) ERβ: identification and characterization of a novel human estrogen receptor. FEBS Lett., 392, 49-53.
48. Onate, S.A., Tsai, S.Y., Tsai, M.-J. and O'Malley, B.W. (1995) Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science, 270, 1354-1357.
49. Parker, M.G. (1993) Steroid and related receptors. Curr. Opin. Cell Biol., 5, 499-504.
50. Parker, M.G. and White, R. (1996) Nuclear receptors spring into action. Nature Struct. Biol., 3, 113-115.
51. Pietras, R.J. et al. (1995) HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. Oncogene, 10, 2435-2446.
52. Power, R.F., Mani, S.K., Codina, J., Conneely, O.M. and O'Malley, B.W. (1991) Dopaminergic and ligand-independent activation of steroid hormone receptors. Science, 254, 1636-1639.
53. Rao, K.V.S. and Fox, C.F. (1987) Epidermal growth factor stimulates tyrosine phosphorylation of human glucocorticoid receptor in cultured cells. Biochem. Biophys. Res. Commun., 144, 512-519.
54. Renaud, J.-P., Rochel, N., Ruff, M., Vivat, V., Chambon, P., Gronemeyer, H. and Moras, D. (1995) Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid. Nature, 378, 681-689.
55. Rochette-Egly, C., Gaub, M.-P., Lutz, Y., Ali, S., Scheuer, I. and Chambon, P. (1992) Retinoic acid receptor-beta: immunodetection and phosphorylation on tyrosine residues. Mol. Endocrinol., 6, 2197-2209.
56. Saatcioglu, F., Bartunek, P., Deng, T., Zenke, M. and Karin, M. (1993) A conserved C-terminal sequence that is deleted in v-ErbA is essential for the biological activities of c-ErbA (the thyroid hormone receptor). Mol. Cell. Biol., 13, 3675-3685.
57. Sleigh, M.J. (1986) A nonchromatographic assay for expression of the chloramphenicol acetyltransferase gene in eucaryotic cells. Anal. Biochem., 156, 251-256.
58. Smith, C.L., Conneely, O.M. and O'Malley, B.W. (1993) Modulation of ligand-independent activation of the human estrogen receptor by hormone and antihormone. Proc. Natl Acad. Sci. USA, 90, 6120-6124.
59. Smith, C.L., Onate, S.A., Tsai, M.-J. and O'Malley, B.W. (1996) CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription. Proc. Natl Acad. Sci. USA, 93, 8884-8888.
60. Tora, L., White, J., Brou, C., Tasset, D., Webster, N., Scheer, E. and Chambon, P. (1989) The human estrogen receptor has two independent nonacidic transcriptional activation functions. Cell, 59, 477-487.
61. Voegel, J.J., Heine, M.J.S., Zechel, C., Chambon, P. and Gronemeyer, H. (1996) TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J., 15, 101-108.
62. vom Baur, E. et al. (1996) Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1. EMBO J., 15, 110-124.
63. Wagner, R.L., Apriletti, J.W., McGrath, M.E., West, B.L., Baxter, J.D. and Fletterick, R.J. (1995) A structural role for hormone in the thyroid hormone receptor. Nature, 378, 690-697.
64. White, R., Jobling, S., Hoare, S.A., Sumpter, J.P. and Parker, M.G. (1994) Environmentally persistent alkylphenolic compounds are estrogenic. Endocrinology, 135, 175-182.
65. Wurtz, J.-M., Bourguet, W., Renaud, J.-P., Vivat, V., Chambon, P., Moras, D. and Gronemeyer, H. (1996) A canonical structure for the ligand-binding domain of nuclear receptors. Nature Struct. Biol., 3, 87-94.
66. Yao, T.-P., Ku, G., Zhou, N., Scully, R. and Livingston, D.M. (1996) The nuclear hormone receptor coactivator SRC-1 is a specific target of p300. Proc. Natl Acad. Sci. USA, 93, 10626-10631.